CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-13 | Care Capital III LLC 10% owner | Grant or award | +30,793,670 | 30,793,670 | ||
| 2018-02-13 | Markham Richard J Director | Grant or award | +30,793,670 | 30,793,670 | ||
| 2018-02-13 | LESCHLY JAN Director | Grant or award | +30,793,670 | 30,793,670 | ||
| 2017-05-18 | ANIDO ARMANDO Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $0.49 | $10K | 75,000 |
| 2017-05-18 | COX GEOFFREY F Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $0.49 | $10K | 103,332 |
| 2017-05-18 | DOUGHERTY MICHAEL R Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $0.49 | $10K | 105,000 |
| 2017-05-18 | Dunne Michael W. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $0.49 | $10K | 75,000 |
| 2017-05-18 | Richard John P Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $0.49 | $10K | 105,000 |
| 2017-05-18 | PLUMB RUSSELL H Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $0.49 | $10K | 622,453 |
| 2017-05-18 | VANLENT ANNE Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $0.49 | $10K | 105,000 |
| 2017-04-03 | COLONNESE MARK P Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | $0.66 | $262K | 775,000 |
| 2017-04-03 | PATTI JOSEPH M CEO | Grant or award · Stock Option (Right to Buy) | +650,000 | $0.66 | $426K | 2,113,304 |
| 2016-08-11 | PATTI JOSEPH M CEO | Grant or award · Stock Option (Right to Buy) | +380,000 | $1.30 | $494K | 1,478,929 |
| 2016-07-27 | COLONNESE MARK P CFO and EVP | Grant or award · Stock Option (Right to Buy) | +150,000 | $1.34 | $201K | 375,000 |
| 2016-05-12 | ANIDO ARMANDO Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $1.50 | $30K | 20,000 |
| 2016-05-12 | COX GEOFFREY F Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $1.50 | $30K | 20,000 |
| 2016-05-12 | DOUGHERTY MICHAEL R Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $1.50 | $30K | 20,000 |
| 2016-05-12 | Dunne Michael W. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $1.50 | $30K | 20,000 |
| 2016-05-12 | PLUMB RUSSELL H Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $1.50 | $30K | 20,000 |
| 2016-05-12 | Richard John P Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $1.50 | $30K | 20,000 |
Page 22 of 23 · 442 trades